Global Health

The question “What is Ebola and why is stopping the latest outbreak so difficult” has taken on renewed urgency. This is because international health authorities declared the latest outbreak in the Democratic Republic of Congo a public health emergency of international concern. Health experts are confronting a combination of challenges

The idea that “GLP-1s appear to protect against cancer” has moved from a niche scientific discussion into a major area of medical research. Originally, these drugs were developed to help manage diabetes and later adopted as highly effective obesity treatments. However, GLP-1 medications are now drawing attention for another possible

Ultra-processed foods are increasingly becoming the focus of public health debates as researchers examine how decades of food manufacturing practices may have contributed to rising rates of obesity, diabetes, cardiovascular disease, and other chronic health conditions. In addition, a growing body of academic research suggests that some of the strategies

The national rollout of Lenacapavir HIV prevention programs in South Africa marks a significant development in the global fight against HIV. Health authorities have begun introducing the long-acting injectable medication across hundreds of healthcare facilities. As a result, they are offering a new prevention strategy that requires only two injections

The upcoming implementation of Medicaid work requirements is generating concern among healthcare advocates, physicians, and patient organizations. They warn that millions of Americans could face disruptions in medical coverage. Among those considered most vulnerable are individuals undergoing cancer treatment and people living with HIV. Also, patients managing chronic conditions may

Forever chemicals exposure has become an increasing public health concern as researchers continue discovering PFAS contamination in drinking water, food supplies, household products, and even human blood samples across the United States. In addition, scientists say these chemicals, formally known as per- and polyfluoroalkyl substances, can remain in the environment

The Congo Ebola outbreak continues expanding across eastern regions of the country as health officials confirmed at least 282 cases linked to the deadly Bundibugyo strain of the virus. Authorities are struggling to contain the outbreak amid insecurity, weak medical infrastructure, and growing pressure on healthcare workers operating in remote

An experimental lung cancer drug developed by Akeso and licensed globally by Summit Therapeutics delivered one of the most closely watched oncology results of the year. The drug reduced the risk of death by 34% during a late-stage clinical trial conducted in China. As a result, the findings immediately intensified

KINSHASA — Ebola clinic attacks in the Democratic Republic of Congo are intensifying concerns among humanitarian organizations and health officials. This is because growing misinformation, panic and anger continue disrupting emergency response operations across affected communities. Several treatment centers handling suspected Ebola patients were attacked within days after the outbreak

UK Advisers Recommend Limited Prostate Cancer Screening Scientific advisers in the United Kingdom have recommended restricting routine prostate cancer screening to a very small group of men considered to be at exceptionally high genetic risk of developing the disease. The proposal follows an extensive review. The review evaluated whether widespread